Literature DB >> 16373546

Drug testing. Massive trial of Celebrex seeks to settle safety concerns.

Jennifer Couzin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16373546     DOI: 10.1126/science.310.5756.1890a

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  5 in total

1.  Targeted deletions of cyclooxygenase-2 and atherogenesis in mice.

Authors:  Yiqun Hui; Emanuela Ricciotti; Irene Crichton; Zhou Yu; Dairong Wang; Jane Stubbe; Miao Wang; Ellen Puré; Garret A FitzGerald
Journal:  Circulation       Date:  2010-06-07       Impact factor: 29.690

2.  Imprecision: Limitations to Interpretation of a Large Randomized Clinical Trial.

Authors:  Garret A FitzGerald
Journal:  Circulation       Date:  2016-11-13       Impact factor: 29.690

3.  Differential impairment of aspirin-dependent platelet cyclooxygenase acetylation by nonsteroidal antiinflammatory drugs.

Authors:  Xuanwen Li; Susanne Fries; Ruizhi Li; John A Lawson; Kathleen J Propert; Scott L Diamond; Ian A Blair; Garret A FitzGerald; Tilo Grosser
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-10       Impact factor: 11.205

Review 4.  The Cardiovascular Pharmacology of Nonsteroidal Anti-Inflammatory Drugs.

Authors:  Tilo Grosser; Emanuela Ricciotti; Garret A FitzGerald
Journal:  Trends Pharmacol Sci       Date:  2017-06-23       Impact factor: 14.819

5.  Nonsteroidal anti-inflammatory drug choice and adverse outcomes in clopidogrel users: A retrospective cohort study.

Authors:  Young Hee Nam; Colleen M Brensinger; Warren B Bilker; Charles E Leonard; Scott E Kasner; Tilo Grosser; Xuanwen Li; Sean Hennessy
Journal:  PLoS One       Date:  2018-03-14       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.